Status:
COMPLETED
A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal
Lead Sponsor:
Allergan
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
50+ years
Brief Summary
This study will evaluate the prevalence of inflammatory dry eye disease in patients prior to cataract surgery. No treatment is administered in this study.
Eligibility Criteria
Inclusion
- Scheduled to undergo cataract removal surgery
Exclusion
- Current use of eye drops or oral medications for allergic conjunctivitis
- Serious ocular injury, intraocular surgery, or refractive surgery within 6 months in the study eye
- Use of a contact lens within 4 weeks
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT01882413
Start Date
June 1 2013
End Date
March 1 2014
Last Update
December 3 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Brandon, Manitoba, Canada
2
Halifax, Nova Scotia, Canada
3
Barrie, Ontario, Canada
4
Ottawa, Ontario, Canada